Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia

被引:8
|
作者
Nowotny, Hanna Franziska [1 ]
Auer, Matthias K. [1 ]
Lottspeich, Christian [1 ]
Schmidt, Heinrich [2 ]
Dubinski, Ilja [2 ]
Bidlingmaier, Martin [1 ]
Adaway, Jo [3 ]
Hawley, James [3 ]
Keevil, Brian [3 ]
Reisch, Nicole [1 ]
机构
[1] LMU Munchen, Klinikum Univ Munchen, Med Klin & Poliklin 4, D-80336 Munich, Germany
[2] LMU Munchen, Dr von Haunersches Childrens Hosp, Dept Pediat Endocrinol, Klinikum Univ Munchen, D-80336 Munich, Germany
[3] Manchester Univ Fdn NHS Trust, Manchester Acad Hlth Sci Ctr, Dept Clin Biochem, Manchester M23 9LT, Lancs, England
来源
关键词
congenital adrenal hyperplasia; saliva; diurnal rhythm; 11-ketotestosterone; 11-oxygenated androgens; STEROIDS; ANDROSTENEDIONE; 17-HYDROXYPROGESTERONE; PROGESTERONE; THERAPY; PLASMA; ADULT;
D O I
10.1210/clinem/dgab446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Several studies have highlighted the importance of the 11-oxygenated 19-carbon (11oxC19) adrenal-derived steroids as potential biomarkers for monitoring patients with 21-hydroxylase deficiency (21OHD). Objective: To analyze circadian rhythmicity of 11oxC19 steroids in saliva profiles and evaluate their relevance as potential monitoring parameters in 21OHD. Design, Setting, and Participants: Cross-sectional single-center study including 59 patients with classic 21OHD (men=30; women=29) and 49 body mass index- and age-matched controls (men=19; women=30). Outcome Measures: Salivary concentrations of the following steroids were analyzed by liquid chromatography-tandem mass spectrometry: 17-hydroxyprogesterone (17OHP), androstenedione (A4), testosterone (T), 11 beta-hydroxyandrostenedione (11OHA4), and 11-ketotestosterone (11KT). Results: Similar to the previously described rhythmicity of 17OHP, 11-OHA4 and 11KT concentrations followed a distinct diurnal rhythm in both patients and controls with highest concentrations in the early morning and declining throughout the day (11OHA4: mean reduction of hormone concentrations between timepoint 1 and 5 (Delta(mean)) in male patients=66%; male controls Delta(mean)=83%; female patients Delta(mean)=47%; female controls Delta(mean)=86%; 11KT: male patients Delta(mean)=57%; male controls Delta(mean)=63%; female patients Delta(mean)=50%; female controls Delta(mean)=76%). Significant correlations between the area under the curve for 17OHP and 11KT (r(male)(p)=0.773(<0.0001); r(female)(p)=0.737(<0.0001)), and 11OHA4 (r(male)(p)=0.633(0.0002); r(female)(p)=0.564(0.0014)) were observed in patients but not present or reduced in controls. Conclusions: Adrenal 11oxC19 androgens are secreted following a diurnal pattern. This should be considered when evaluating their utility for monitoring treatment control.
引用
收藏
页码:E4509 / E4519
页数:11
相关论文
共 50 条
  • [1] Salivary profiles of 11-oxygenated androgens follow a diurnal rhythm in patients with congenital adrenal hyperplasia
    Nowotny, Hanna F.
    Auer, Matthias K.
    Lottspeich, Christian
    Schmidt, Heinrich
    Dubinski, Ilja
    Bidlingmaier, Martin
    Adaway, Jo
    Hawley, James
    Keevil, Brian
    Reisch, Nicole
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 25 - 25
  • [2] 11-oxygenated androgens as biomarkers in congenital adrenal hyperplasia: reference intervals for children
    Adriaansen, Bas P. H.
    Oude-Alink, Sandra
    Swinkels, Dorine W.
    Schroder, Mariska A. M.
    Span, Paul N.
    Sweep, Fred C. G. J.
    Claahsen-van der Grinten, Hedi L.
    van Herwaarden, Antonius E.
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 150 - 151
  • [3] Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia
    Kamrath, Clemens
    Wettstaedt, Lisa
    Boettcher, Claudia
    Hartmann, Michaela F.
    Wudy, Stefan A.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 178 : 221 - 228
  • [4] Cortisol and 11-oxygenated androgens in hair samples from children and adolescents with congenital adrenal hyperplasia
    Dubinski, Ilja
    Krumbholz, Aniko
    Schmidt, Heinrich
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 461 - 461
  • [5] 11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia
    Auer, Matthias K.
    Paizoni, Luisa
    Neuner, Meike
    Lottspeich, Christian
    Schmidt, Heinrich
    Bidlingmaier, Martin
    Hawley, James
    Keevil, Brian
    Reisch, Nicole
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2021, 212
  • [6] Production of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors
    Schroder, Mariska A. M.
    Turcu, Adina F.
    O'Day, Patrick
    van Herwaarden, Antonius E.
    Span, Paul N.
    Auchus, Richard J.
    Sweep, Fred C. G. J.
    Claahsen-van der Grinten, Hedi L.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (01): : E272 - E280
  • [7] ANDROGEN EXCESS IN YOUNG CHILDREN WITH CLASSIC CONGENITAL ADRENAL HYPERPLASIA TREATED WITH HYDROCORTISONE IS DUE TO ELEVATED ADRENAL-DERIVED 11-OXYGENATED ANDROGENS
    Kamrath, Clemens
    Wettstaedt, Lisa
    Boettcher, Claudia
    Hartmann, Michaela F.
    Wudy, Stefan A.
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 247 - 247
  • [8] Salivary 11-oxygenated 19-carbon steroids in children with congenital adrenal hyperplasia and Addison's disease compared to healthy children
    Park, Julie
    Hawcutt, Daniel
    Shantsila, Alena
    Bright, Orla
    Dliso, Silothabo
    Lip, Gregory
    Blair, Joanne
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 148 - 149
  • [9] Circulating adrenal 11-oxygenated androgens are associated with clinical outcome in endometrial cancer
    Dahmani, Cylia
    Caron, Patrick
    Simonyan, David
    Turcotte, Veronique
    Gregoire, Jean
    Plante, Marie
    Guillemette, Chantal
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [10] STUDIES OF ANDROGENS IN PATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA
    RIVAROLA, MA
    SAEZ, JM
    MIGEON, CJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (05): : 624 - +